The same report also identifies breast cancer anti-estrogen resistance protein 1 (BCAR1) to be a substrate of BRK, where in vivo knockdown of BRK disrupts phosphorylation of BCAR1 tyrosine residue 165, preventing its activation. The gene discussed is PTK6; the disease is breast cancer.